About 183,000 results
Open links in new tab
Bristol Myers Squibb's Karuna buyout pays off with FDA approval …
BMS wins approval for schizophrenia drug acquired from Karuna
Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics ...
Bristol Myers Squibb Strengthens Neuroscience Portfolio with ...
Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion
Bristol Myers Squibb acquires Karuna Therapeutics for $14 billion ...
Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics …
Bristol Myers Squibb to buy Karuna Therapeutics - CNBC
Bristol’s $14 Billion Karuna Deal Highlights Race for New Drugs
First new type of treatment for schizophrenia in decades : Shots